The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Interstitial lung disease 2
SANDOSTATIN LAR DEPOT Intervertebral disc degeneration 2
SANDOSTATIN LAR DEPOT Intestinal fistula 2
SANDOSTATIN LAR DEPOT Intestinal mass 2
SANDOSTATIN LAR DEPOT Intestinal strangulation 2
SANDOSTATIN LAR DEPOT Intracranial aneurysm 2
SANDOSTATIN LAR DEPOT Ligament injury 2
SANDOSTATIN LAR DEPOT Lip dry 2
SANDOSTATIN LAR DEPOT Lip injury 2
SANDOSTATIN LAR DEPOT Lymphocyte percentage decreased 2
SANDOSTATIN LAR DEPOT Malaria 2
SANDOSTATIN LAR DEPOT Mean cell haemoglobin concentration increased 2
SANDOSTATIN LAR DEPOT Mean cell volume increased 2
SANDOSTATIN LAR DEPOT Melanocytic naevus 2
SANDOSTATIN LAR DEPOT Menopausal symptoms 2
SANDOSTATIN LAR DEPOT Mental impairment 2
SANDOSTATIN LAR DEPOT Mesothelioma malignant 2
SANDOSTATIN LAR DEPOT Metastases to chest wall 2
SANDOSTATIN LAR DEPOT Metastatic neoplasm 2
SANDOSTATIN LAR DEPOT Micturition disorder 2

Total Records: 2,045     Number of Pages: 103